{"lc": {"ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds": {"story_link": "https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "user_code": "GOLD_27", "age_group": "upto_20", "agreed": true, "close_date_time": "2021-10-30 19:16:57", "close_timestamp": 1638299817266, "created": "30/11/2021 19:16:59", "department": "Computing", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-30", "gender": "female", "id": "b39e4737-c117-4180-989e-36dbd599b555", "open_date_time": "2021-10-30 19:12:9", "open_timestamp": 1638299529767, "story_date": "2020-04-21 00:00:00", "story_source": "tpl", "story_title": "Ivermectin can kill COVID-19 within 48 hours', Monash University study finds", "summary": "This story is about a doctor describing his research and study into Ivermectin and how he found that it can kill COVID-19. ", "task_condition": "viz", "task_key": "ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "task_level": "under_graduate_year_2", "time_taken_in_seconds": 287499, "what": "Doctor finds a cure for COVID-19", "when_happened": "few_years_ago", "where_location": "Monash University", "who": "Dr Kylie Wagstaff", "why": "It is very useful for development as other doctors can use his research to treat other patients. "}, "challenges-expected-for-novavax-covid-19-vaccine-in-usa": {"story_link": "https://www.thepharmaletter.com/article/challenges-expected-for-novavax-covid-19-vaccine-in-usa", "user_code": "GOLD_27", "age_group": "upto_20", "agreed": true, "close_date_time": "2021-10-30 19:38:27", "close_timestamp": 1638301107475, "created": "30/11/2021 19:38:30", "department": "Computing", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-30", "gender": "female", "id": "055637c1-d0c5-4f1c-b10f-37ee40db8991", "open_date_time": "2021-10-30 19:27:50", "open_timestamp": 1638300470623, "story_date": "2021-06-23 00:00:00", "story_source": "tpl", "story_title": "Challenges expected for Novavax' COVID-19 vaccine in USA", "summary": "The story is about descibes Novavax's experiment into what effect his vaccine has on covid. It goes through his experiment and gives details about the results he obtained. ", "task_condition": "text", "task_key": "challenges-expected-for-novavax-covid-19-vaccine-in-usa", "task_level": "under_graduate_year_2", "time_taken_in_seconds": 636852, "what": "The Novavax vaccine not being used as much as it should in the USA", "when_happened": "few_month_ago", "where_location": "America", "who": "Novavax", "why": "It gives detailed information about the vaccine and explains the positve effects which may resulting it being used more in the US. "}, "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19": {"story_link": "https://www.thepharmaletter.com/article/australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "user_code": "GOLD_27", "age_group": "upto_20", "agreed": true, "close_date_time": "2021-10-30 19:27:35", "close_timestamp": 1638300455570, "created": "30/11/2021 19:27:37", "department": "Computing", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-30", "gender": "female", "id": "ace8ab00-8d0e-41cb-b99e-98cb32bd4679", "open_date_time": "2021-10-30 19:17:7", "open_timestamp": 1638299827609, "story_date": "2020-08-20 00:00:00", "story_source": "tpl", "story_title": "Australian GPs urged to prescribe ivermectin triple therapy to fight COVID-19", "summary": "The story is about a gastroenterologist named Thomas Broody from Australia who believes that GPs should begin to prescribe ivermectin to help kill COVID-19.", "task_condition": "text", "task_key": "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "task_level": "under_graduate_year_2", "time_taken_in_seconds": 627961, "what": "Thomas Borody's opinion that ivermectin can cure covid and that GPs should begin to prescribe it.", "when_happened": "few_month_ago", "where_location": "Australia", "who": "Thomas Borody", "why": "It can create more awareness about ivermectin and could spark further research into it and see how it can kill cover and its other uses. "}, "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve": {"story_link": "https://www.thepharmaletter.com/article/japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "user_code": "GOLD_27", "age_group": "upto_20", "agreed": true, "close_date_time": "2021-10-30 19:11:54", "close_timestamp": 1638299514100, "created": "30/11/2021 19:11:56", "department": "Computing", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-30", "gender": "female", "id": "8633cc2f-6af1-41b9-8006-d6bdc71e6c9e", "open_date_time": "2021-10-30 18:56:45", "open_timestamp": 1638298605154, "story_date": "2020-07-21 00:00:00", "story_source": "tpl", "story_title": "Japan is first country to approve COVID-19 cocktail Ronapreve", "summary": "The doctor is descriibing the how the cocktail ronapreve works and is describing the effects of it on the body after its use.  ", "task_condition": "viz", "task_key": "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "task_level": "under_graduate_year_2", "time_taken_in_seconds": 908946, "what": "COVID-19 Cocktail Ronapreve", "when_happened": "few_years_ago", "where_location": "Japan", "who": "Dr Osamu Okuda", "why": "it provides information about the COVID-19 cocktail Ronapreve and its effects which can be useful in development and research. "}}, "tb": {"pfizer": {"story_term": "pfizer", "user_code": "GOLD_27", "age_group": "upto_20", "agreed": true, "close_date_time": "2021-10-30 20:12:35", "close_timestamp": 1638303155104, "created": "30/11/2021 20:12:36", "department": "Computing", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-30", "gender": "female", "id": "b787b484-af37-4228-94aa-ba13cd2def1d", "open_date_time": "2021-10-30 20:0:54", "open_timestamp": 1638302454770, "summary": "It has now been discovered that there are multiple strains of COVID-19 and one of these strains are called the Indian strain. The organisation Pfizer has created a vaccine for the Indian strain and the public health authorirties in the UK say that it is effective against the variant. Pfizer made a mRNA-based vaccine and research shows that two weeks after the second dose of the vaccine there is 88% protection against the Indian strain. As also commented by British Health Secretary Matt Hancock Pfizer's research is 'ground-breaking' which is very useful as they have made a huge impact in the control of the new strain, and can also help to  control any other strains that may be discovered in the future. ", "task_condition": "text", "task_key": "pfizer", "task_level": "under_graduate_year_2", "time_taken_in_seconds": 700334}, "astrazeneca": {"story_term": "astrazeneca", "user_code": "GOLD_27", "age_group": "upto_20", "agreed": true, "close_date_time": "2021-10-30 20:0:39", "close_timestamp": 1638302439959, "created": "30/11/2021 20:00:42", "department": "Computing", "disability": false, "ease": 2, "environment": "production", "experiment_date_datepicker": "2021-11-30", "gender": "female", "id": "aac721dd-b470-41cc-9d07-53bd8fa16ecb", "open_date_time": "2021-10-30 19:41:37", "open_timestamp": 1638301297673, "summary": "Astrazeneca is a Uk based organisation that has made a huge impact in oncology. They have sparked further research into Lynparza after their presentation at the American Society of Clinical Oncology (ASCO) on June 4th. They have helped to discover that Lynparza can be used for many treatments. At the ASCO they also did an oral presentation which described the results of a study that they did into adavosertib with and without Lynparza in women with ovarian cancer. Their work I the oncology sector has been groundbreaking and will hopefully lead to greater development into cures for cancer and tumours. ", "task_condition": "viz", "task_key": "astrazeneca", "task_level": "under_graduate_year_2", "time_taken_in_seconds": 1142286}}}